Fredric J. Feldman, Director at Capstone Therapeutics Corp. (CAPS), bought 25,000 shares at $0.21 ($5K) on 2013-04-08, disclosed to the SEC on 2013-04-10.
Open-market purchase of $5k CAPS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| OLGC | BUY | 2008-08-25 | $8K | — | Filing → |
| OLGC | BUY | 2008-03-14 | $9K | — | Filing → |